Growth Metrics

Organon (OGN) Capital Expenditures (2020 - 2025)

Organon has reported Capital Expenditures over the past 6 years, most recently at $45.0 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $45.0 million for Q4 2025, down 18.18% from a year ago — trailing twelve months through Dec 2025 was $162.0 million (down 7.43% YoY), and the annual figure for FY2025 was $162.0 million, down 7.43%.
  • Capital Expenditures for Q4 2025 was $45.0 million at Organon, down from $46.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for OGN hit a ceiling of $79.0 million in Q4 2023 and a floor of $32.0 million in Q2 2024.
  • Median Capital Expenditures over the past 5 years was $46.0 million (2023), compared with a mean of $48.8 million.
  • Biggest five-year swings in Capital Expenditures: surged 57.78% in 2023 and later plummeted 54.93% in 2024.
  • Organon's Capital Expenditures stood at $59.0 million in 2021, then grew by 6.78% to $63.0 million in 2022, then rose by 25.4% to $79.0 million in 2023, then tumbled by 30.38% to $55.0 million in 2024, then fell by 18.18% to $45.0 million in 2025.
  • The last three reported values for Capital Expenditures were $45.0 million (Q4 2025), $46.0 million (Q3 2025), and $39.0 million (Q2 2025) per Business Quant data.